Table 8.
DVH differences between clinical plans and those obtained using the prostate model
Structure | Clinical goal | Difference | |
---|---|---|---|
Average | Standard deviation | ||
PTV | D99% (%) | 0.32 | 1.01 |
V105% (cm3) | −1.95 | 8.88 | |
Bladdera | V80 Gy ≤ 15% | −0.04 | 0.75 |
V75 Gy ≤ 25% | 0.16 | 0.43 | |
V70 Gy ≤ 35% | 0.09 | 0.29 | |
V65 Gy ≤ 50% | −1.61 | 6.85 | |
V40 Gy ≤ 70% | −0.54 | 3.15 | |
Rectuma | V75 Gy ≤ 15% | 0.31 | 0.94 |
V70 Gy ≤ 20% | 0.26 | 0.94 | |
V65 Gy ≤ 25% | −0.97 | 3.77 | |
V60 Gy ≤ 35% | 0.05 | 1.59 | |
V50 Gy ≤ 50% | −0.26 | 3.02 | |
V40 Gy ≤ 55% | 0.27 | 3.96 | |
Femoral headsa | V53 Gy ≤ 5% | 0.00 | 0.00 |
V50 Gy ≤ 10% | −0.01 | 0.04 |
Trained structure.